Eevia Health Plc (“Eevia” or “The Company”) is welcoming Dr. Tommi Kilpeläinen as its new Scientific Product Manager.

Tommi Kilpeläinen is educated as a Doctor of Pharmacy (Ph.D.) in pharmacology and pharmaceutical chemistry, and he is also a certified pharmacist. He will head the strategic positioning of Eevia Health’s nutraceutical product portfolio and spearhead Eevia’s strategy to become a leader in products aimed to support and enhance cellular recycling to maintain healthy cell function.

Dr. Kilpeläinen started in the new position in Eevia in October 2022 and is working full-time for Eevia Health as a member of the Senior Leader Team. Before joining Eevia Health, he worked as a post-doctoral researcher at the University of Helsinki, where he managed research in neuroscience and lead compound discovery. He has special skills related to autophagy processes in human cells and, molecular biology methods and pre-clinical animal models.

“We are very pleased to welcome Tommi to bring our products to the forefront of the nutraceutical industry. The strategic choice Eevia Health is making to focus on extracts that support cellular health and autophagy is a perfect match with Dr. Kilpeläinens’s expertise and research background. The demand for products with efficacy in autophagy induction (cellular recycling), and cognitive health will skyrocket in the future. Eevia Health will position itself to be a leading ingredient provider within this category and Tommi will contribute to our Team’s ability to execute this strategy,” comments Stein Ulve, CEO of Eevia Health Plc.

Dr. Kilpeläinen explains his interest in Eevia Health: «I am a scientifically oriented person with a great interest in lead compound development, in which I can use my innovative and productive approach and passion for finding new solutions and applications. Eevia Health has an inspiring mission to valorize solutions from science on natural plant extracts and turn this into commercial products and contribute to people’s health and well-being.»